发明名称 ANTI-PD1 ANTIBODIES, ACTIVATABLE ANTI-PD1 ANTIBODIES, AND METHODS OF USE THEREOF
摘要 The invention relates generally to antibodies that specifically bind programmed cell death protein 1 (PD-1), activatable antibodies that specifically bind to PD-1 and methods of making and using these anti-PD-1 antibodies and anti-PD-1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
申请公布号 US2017044259(A1) 申请公布日期 2017.02.16
申请号 US201615209385 申请日期 2016.07.13
申请人 CytomX Therapeutics, Inc. 发明人 Tipton Kimberly Ann;West James William;Chan Chanty Mariategue
分类号 C07K16/28;C07K16/30;A61K39/395;A61K47/48 主分类号 C07K16/28
代理机构 代理人
主权项 1. An isolated antibody or antigen binding fragment thereof (AB) that specifically binds to mammalian PD-1, wherein the AB has one or more of the characteristics selected from the group consisting of: (a) the AB inhibits binding of mammalian PD-1 to mammalian PDL1 with an EC50 value less than 5 nM; (b) the AB inhibits binding of mammalian PD-1 to mammalian PDL2 with an EC50 value less than 5 nM; and (c) the AB specifically binds to human PD-1 and cynomolgus monkey PD-1.
地址 South San Francisco CA US